@def title = "Presentations"

## Presentations

**Metalearners for Heterogeneous Treatment Effects on Survival Outcomes in Experiments.**\\
American Causal Inference Conference ([ACIC](https://ctml.berkeley.edu/american-causal-inference-conference-2022))\\
May 2022, University of California, Berkeley\\
\poster{https://drive.google.com/file/d/12X7TdcC84VNsU3wiH-qi4lVufECv2JCo/view}

**Calibration Error for Heterogeneous Treatment Effects.**\\
International Conference on Artificial Intelligence and Statistics ([AISTATS](http://aistats.org/aistats2022/))\\
March 2022, Virtual\\
\poster{https://drive.google.com/file/d/1NgcUV30qwxmyKujRToi2_BxcEviuPThl/view} \youtube{https://subtitles-editor.slideslive.com/#/editor/38980737?token=jzBAyW5OZ7HLH4hz1FzhZLmy}

**A Conditional Random Forest Approach to Estimating the Most Cost-effective Individualized Treatment Rule.**\\
Journal of Statistical Meetings, Health Policy Statistics Section ([JSM](https://ww2.amstat.org/meetings/jsm/2021/))\\
August 2021, Virtual\\
\slides{https://drive.google.com/file/d/1tBZFSU0nvyFyfz53JvzgKqez4BtW3glU/view}

**Estimating the Optimal Individualized Treatment Rule from A Cost-Effectiveness Perspective.**\\
American Statistical Association, Biopharmaceutical Section Regulatory-Industry Statistics Workshop Program ([ASA](https://ww2.amstat.org/meetings/biop/2019/))\\
September 2019, Washington D.C.\\
\poster{https://drive.google.com/file/d/1x7PmrL39IlU1xfWbOcJVs6wR4dSgQTnz/view}

**Random-Forest Based Personalized Treatment Rule Optimization from A Cost-Effectiveness Perspective with An Application to the SPRINT Study.**\\
[The 3rd Annual Translational Hypertension Symposium and Early-Stage Investigator Workshop](https://uofuhealth.utah.edu/newsroom/news/2019/09/htn.php)\\
September 2019, University of Utah\\

**Was the Effect of Intensive Blood Pressure Intervention on CVD Risk Heterogeneous in the SPRINT Study?**\\
[The 2nd Annual Translational Hypertension Symposium and Early-Stage Investigator Workshop](https://ctsi.utah.edu/news/2018/07/2nd-annual-translational-hypertension-symposium-and-early-stage-investigator-workshop)\\
September 2018, Salt Lake City, Utah\\
\poster{https://drive.google.com/file/d/1lsR33FZMpoCZh82j7LJgQLdkXBjqCk9A/view}

**Optimal Study Design for Diagnostic Accuracy Studies: Differential Verification versus Partial Verification.**\\
Association for Clinical and Translational Science ([ACTS](https://nrmnet.net/blog/faculty/2017/06/14/2017-association-for-clinical-and-translational-science-acts-meeting-features-sessions-by-nrmn/))\\
September 2017, Washington D.C.\\
\poster{https://drive.google.com/file/d/1P7eK2TdaQaaJZNnilltUdq9ZFru1pP74/view}
